Iovance Biotherapeutics
IOVA
IOVA
122 hedge funds and large institutions have $1.31B invested in Iovance Biotherapeutics in 2018 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 52 increasing their positions, 18 reducing their positions, and 7 closing their positions.
Holders
122
Holders Change
+35
Holders Change %
+40.23%
% of All Funds
2.8%
Holding in Top 10
9
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+350%
% of All Funds
0.21%
New
43
Increased
52
Reduced
18
Closed
7
Calls
$7.71M
Puts
$1.57M
Net Calls
+$6.14M
Net Calls Change
+$5.55M
Top Buyers
Top Sellers
| 1 |
BC
1
Broadfin Capital
New York
|
$15.4M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$8.62M |
| 3 |
3
Axa
Paris,
France
|
$1.43M |
| 4 |
PM
4
Prosight Management
Dallas,
Texas
|
$3.55M |
| 5 |
5
Millennium Management
New York
|
$8.63M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TI
126
Trexquant Investment
Stamford,
Connecticut
| – | – | -15,464 | Closed |
|
127
Parallax Volatility Advisers
San Francisco,
California
| – | – | -9,408 | Closed |
|
|
DCM
128
Delpha Capital Management
New York
| – | – | -833 | Closed |
|
|
II
129
Inspire Investing
Meridian,
Idaho
| – | – | -164 | Closed |
|
|
CA
130
Calton & Associates
Tampa,
Florida
| – | – | – | – |
|
|
HT
131
HAP Trading
New York
| – | – | – | – |
|
132
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|